The Guardian - Pharmaceutical Industry
DECEMBER 4, 2023
Under a court reorganization plan, Sackler family members who controlled the Oxycontin maker were granted immunity and did not have to declare personal bankruptcy in exchange for a $6bn settlement, paid out over 10 years, to a fund created to offset costs created by the opioid dependency crisis that has cost hundreds of thousands of lives.
pharmaphorum
DECEMBER 17, 2021
The Sacklers said earlier they would exit the settlement deal if they were not granted immunity, and the judge in the bankruptcy court that accepted the deal – Robert Drain – said he did not want to jeopardise what was on offer by seeking further changes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 2, 2021
A US federal judge has approved a bankruptcy settlement for Purdue Pharma that grants the Sackler family that owned the business immunity from any further civil lawsuits accusing them of contributing to opioid epidemic – to the consternation of campaigners.
NY Times
JULY 4, 2021
France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own.
Pharmacy Joe
SEPTEMBER 23, 2021
In this episode, I’ll discuss a possible syndrome that might herald vaccine-induced immune thrombotic thrombocytopenia. Episode 646: Does vaccine-induced immune thrombotic thrombocytopenia have a “pre-VITT syndrome” ? 4 of the patients experienced thrombosis and 7 did not. appeared first on Pharmacy Joe.
NY Times
APRIL 15, 2021
Many cannot produce enough infection-fighting cells to fend off the coronavirus. But researchers are testing one therapy that may help: monoclonal antibodies.
European Pharmaceutical Review
MARCH 19, 2024
This pathway works in the innate immune system to sense cytosolic DNA by triggering a STING-dependent inflammatory response. In September 2019, IFM Due entered into an option and collaboration agreement with Novartis, who agreed to finance IFM Due’s research and development costs for the cGAS-STING programme.
Expert insights. Personalized for you.
47 
Let's personalize your content